POAS
Phaos Technology Holdings (Cayman) Limited
NYSE MKT: POAS · HEALTHCARE · MEDICAL DEVICES
$2.34
+5.41% today
Updated 2026-04-30
Market cap
$29.33M
P/E ratio
—
P/S ratio
174.91x
EPS (TTM)
$-0.30
Dividend yield
—
52W range
$1 – $7
Volume
0.3M
Phaos Technology Holdings (Cayman) Limited (POAS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating cash flow | $-1.79M | $-1.61M | $-3.65M |
| Capital expenditures | $217636.00 | $121318.00 | $240212.00 |
| Depreciation | — | — | — |
| Stock-based comp | — | — | — |
| Free cash flow | $-2.01M | $-1.73M | $-3.89M |
| Investing cash flow | — | — | — |
| Financing cash flow | — | — | — |
| Dividends paid | — | — | — |
| Share repurchases | — | — | — |
| Debt repayment | — | — | — |
| Net change in cash | — | — | — |